Nabel GJ - Search Results

1

Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections.

Promsote W, Xu L, Hataye J, Fabozzi G, March K, Almasri CG, DeMouth ME, Lovelace SE, Talana CA, Doria-Rose NA, McKee K, Hait SH, Casazza JP, Ambrozak D, Beninga J, Rao E, Furtmann N, Birkenfeld J, McCarthy E, Todd JP, Petrovas C, Connors M, Hebert AT, Beck J, Shen J, Zhang B, Levit M, Wei RR, Yang ZY, Pegu A, Mascola JR, Nabel GJ, Koup RA. Promsote W, et al. Among authors: nabel gj. Nat Commun. 2023 Jun 22;14(1):3719. doi: 10.1038/s41467-023-39265-z. Nat Commun. 2023. PMID: 37349337 Free PMC article.

2

Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.

Liu J, Woffendin C, Yang ZY, Nabel GJ. Liu J, et al. Among authors: nabel gj. Gene Ther. 1994 Jan;1(1):32-7. Gene Ther. 1994. PMID: 7584057

3

Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells.

Woffendin C, Yang ZY, Udaykumar, Xu L, Yang NS, Sheehy MJ, Nabel GJ. Woffendin C, et al. Among authors: nabel gj. Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11581-5. doi: 10.1073/pnas.91.24.11581. Proc Natl Acad Sci U S A. 1994. PMID: 7972106 Free PMC article.

4

Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.

Woffendin C, Ranga U, Yang Z, Xu L, Nabel GJ. Woffendin C, et al. Among authors: nabel gj. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2889-94. doi: 10.1073/pnas.93.7.2889. Proc Natl Acad Sci U S A. 1996. PMID: 8610137 Free PMC article.

5

Cell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory gene.

Ranga U, Woffendin C, Yang ZY, Xu L, Verma S, Littman DR, Nabel GJ. Ranga U, et al. Among authors: nabel gj. J Virol. 1997 Sep;71(9):7020-9. doi: 10.1128/JVI.71.9.7020-7029.1997. J Virol. 1997. PMID: 9261432 Free PMC article.

6

Immunization for Ebola virus infection.

Xu L, Sanchez A, Yang Z, Zaki SR, Nabel EG, Nichol ST, Nabel GJ. Xu L, et al. Among authors: nabel gj, nabel eg. Nat Med. 1998 Jan;4(1):37-42. doi: 10.1038/nm0198-037. Nat Med. 1998. PMID: 9427604

7

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.

Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ. Yang ZY, et al. Among authors: nabel gj, nabel eg. Nat Med. 2000 Aug;6(8):886-9. doi: 10.1038/78645. Nat Med. 2000. PMID: 10932225

8

Development of a preventive vaccine for Ebola virus infection in primates.

Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ. Sullivan NJ, et al. Among authors: nabel gj. Nature. 2000 Nov 30;408(6812):605-9. doi: 10.1038/35046108. Nature. 2000. PMID: 11117750

9

Challenges and opportunities for development of an AIDS vaccine.

Nabel GJ. Nabel GJ. Nature. 2001 Apr 19;410(6831):1002-7. doi: 10.1038/35073500. Nature. 2001. PMID: 11309631 Review.

10

Vaccines for the prevention of HIV-1 disease.

Mascola JR, Nabel GJ. Mascola JR, et al. Among authors: nabel gj. Curr Opin Immunol. 2001 Aug;13(4):489-95. doi: 10.1016/s0952-7915(00)00246-6. Curr Opin Immunol. 2001. PMID: 11498307 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

422 results

Search Page

Filters